Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
DiaSorin SpA
34DDiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy. Address: Via Crescentino, Saluggia, VC, Italy, 13040
Analytics
Preço Alvo de Wall Street
–Rácio P/E
33.7624Rendimento de dividendos
1.12 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave 34D
Análise de Dividendos 34D
Crescimento de dividendos em 5 anos
-58 %Crescimento contínuo
3 anosTaxa de pagamento em média de 5 anos
30 %Histórico de Dividendos 34D
Avaliação de ações 34D
Relatório 34D
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |